. 2016 May 25;18(9):857–863. doi: 10.1111/jch.12843

Table 3.

Delta cfPWV Among Patients Who Developed vs Patients Who Did Not Develop CV Events During the 12‐Month Follow‐Up Period

Clinical Event	Delta cfPWV, Median (IQR), m/s N=66		P Value
Clinical Event	No Event	Event	P Value
New CV event^a	0.96 (−0.36 to 2.31) (n=53)	2.47 (0.96–6.00) (n=13)	.09
CV death	1.07 (−0.25 to 2.60) (n=59)	2.47 (−1.47 to 15.06) (n=7)	.20
ACS	1.01 (−0.37 to 2.60) (n=62)	2.06 (1.29–9.77) (n=4)	.37
Acute ischemic PAD	1.10 (−0.37 to 2.60) (n=62)	2.62 (0.46–5.26) (n=4)	.49

Abbreviations: cfPWV, carotid‐femoral pulse wave velocity; IQR, interquartile range; PAD, peripheral arterial disease. ^aNew cardiovascular (CV) event was defined as the composite of either CV death, acute coronary syndrome (ACS), significant acute ischemic peripheral arterial events necessitating intervention, or stroke. There were no stroke events in the cohort during the 12‐month follow‐up period.